Nicholas Brousseau
Dr. Nicholas Brousseau is a Canadian preventative medicine specialist based in Quebec City, Quebec.
Education
Brousseau completed his education at Laval University in 2011.1)
Career and Affiliations
Public Health England
Following his education, he completed a research fellowship on vaccine-preventable diseases in the Centre for Infectious Disease Surveillance and Control and the Immunisation, Hepatitis and Blood Safety Department at Public Health England in London. In that position, he published research on influenza and pneumococcal vaccination, as well as hepatitis B infection.2) 3) 4) 5)
Institut national de santé publique du Québec
Brousseau joined the Quebec Ministry of Health and Social Services in 2015.6)
Quebec Immunization Committee
He has been a Member of the Quebec Immunization Committee since 2016.7)
Laval University
Brousseau joined the Centre de recherche du CHU de Québec at Laval University in 2019, where is also a Clinical Associate Professor.
National Advisory Committee on Immunization
Brousseau is a member of the National Advisory Committee on Immunization.8)
Research
Brousseau conducts research on vaccine-preventable diseases. His areas of expertise are vaccination against pertussis, tetanus, pneumococcus, influenza and COVID-19 (immunogenicity, efficacy and impact of vaccination). He also conducts work on the optimization of vaccination services in Quebec. In 2020, he established a study on the seroprevalence of antibodies against the SARS-CoV-2 in health care workers in 10 hospital centers in Quebec.
Funding
Research funding for Brousseau's studies has come from Merck and the Quebec Ministry of Health and Social Services.9)
Media
Presentations
Brousseau has given presentations at scientific conferences, including the Canadian Immunization Conference (CIC).
1)
, 8)
, 9)
Public Health Agency of Canada. (2022, February 25). National Advisory Committee on Immunization (NACI): Membership and representation. Government of Canada. https://web.archive.org/web/20220318105951/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html#fn1-rf
2)
Green, H. K., Brousseau, N., Andrews, N., Selby, L., & Pebody, R. (2016). Illness absenteeism rates in primary and secondary schools in 2013–2014 in England: was there any impact of vaccinating children of primary-school age against influenza? Epidemiology and Infection, 144(16), 3412–3421. https://doi.org/10.1017/s0950268816001680
3)
Brousseau, N., Andrews, N., Waight, P., Stanford, E., Newton, E., Almond, R., Slack, M. P. E., Miller, E., Borrow, R., & Ladhani, S. N. (2015). Antibody Concentrations Against the Infecting Serotype in Vaccinated and Unvaccinated Children With Invasive Pneumococcal Disease in the United Kingdom, 2006–2013. Clinical Infectious Diseases, 60(12), 1793–1801. https://doi.org/10.1093/cid/civ164
4)
Brousseau, N., Murphy, D. G., Gilca, V., Larouche, J., Mandal, S., & Tedder, R. S. (2017). Acute hepatitis B virus infection with delayed appearance of hepatitis B core antibody in an immunocompromised patient: a case report. Journal of Medical Case Reports, 11(1). https://doi.org/10.1186/s13256-017-1264-9
5)
Brousseau, N., Green, H. K., Andrews, N., Pryse, R., Baguelin, M., Sunderland, A., Ellis, J., & Pebody, R. (2015). Impact of influenza vaccination on respiratory illness rates in children attending private boarding schools in England, 2013–2014: a cohort study. Epidemiology and Infection, 143(16), 3405–3415. https://doi.org/10.1017/s0950268815000667
6)
Nicholas Brousseau. Université de Laval. Retrieved May 21, 2022, from https://archive.ph/eUtra
7)
Comité sur l’immunisation du Québec (CIQ). INSPQ. Retrieved March 22, 2022, from https://archive.ph/9eVKx